Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2969617 | The Journal of Heart and Lung Transplantation | 2016 | 8 Pages |
Abstract
In this prospective, open, randomized study comparing early CNI withdrawal with mammalian target of rapamycin inhibitors immunosuppression during the first year after HTx, early transition from CNI-based immunosuppression to EVR-based treatment did not result in differences in microvascular function as assessed by the IMR.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Ole Geir MD, Knut MD, MPH, PhD, Asgrimur MD, Dan MD, Satish MD, PhD, Knut MD, PhD, JÅ«ratÄ Å altytÄ PhD, Lars MD, PhD, Einar MD, PhD, Arne K. MD, PhD, Lars MD, PhD,